TY - ABST
T1 - Oral Plasma Kallikrein Inhibitor BCX7353 is Safe and Effective as an On-Demand Treatment of Angioedema Attacks in Hereditary Angioedema (HAE) Patients: Results of the ZENITH-1 Trial
AU - Longhurst, Hilary
AU - Moldovan, Dumitru
AU - Bygum, Anette
AU - Cicardi, Marco
AU - Huissoon, Aarnoud
AU - Aygoren-Pursun, Emel
AU - Grivcheva-Panovska, Vesna
AU - Hagin, David
AU - Steiner, Urs
AU - Stobiecki, Marcin
AU - Aberer, Werner
AU - Bethune, Claire
AU - Faust, Saul N.
AU - Kiani, Sorena
AU - Launay, David
AU - Maurer, Marcus
AU - Rae, William
AU - Reshef, Avner
AU - Cornpropst, Melanie T.
AU - Dobo, Sylvia M.
AU - VanDyke, Sharon
AU - Murray, Sharon
AU - Collis, Phillip J.
AU - Sheridan, William P.
AU - Farkas, Henriette
N1 - Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI), San Francisco, CA, FEB 22-25, 2019
PY - 2019/2/1
Y1 - 2019/2/1
U2 - 10.1016/j.jaci.2018.12.112
DO - 10.1016/j.jaci.2018.12.112
M3 - Conference abstract in journal
SN - 0091-6749
VL - 143
SP - AB37
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - Suppl. 2
T2 - AAAAI Annual Meeting 2019
Y2 - 22 February 2019 through 25 February 2019
ER -